Ontario Teachers Pension Plan Board Acquires 3,310 Shares of Solventum Co. (NYSE:SOLV)

Ontario Teachers Pension Plan Board lifted its stake in shares of Solventum Co. (NYSE:SOLV) by 13.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 28,298 shares of the company’s stock after buying an additional 3,310 shares during the period. Ontario Teachers Pension Plan Board’s holdings in Solventum were worth $1,869,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Modus Advisors LLC bought a new position in shares of Solventum during the fourth quarter worth about $25,000. Stonebridge Financial Group LLC acquired a new position in shares of Solventum in the 4th quarter worth approximately $26,000. Crews Bank & Trust bought a new stake in shares of Solventum in the 4th quarter valued at $32,000. Synergy Asset Management LLC acquired a new stake in shares of Solventum during the fourth quarter worth $35,000. Finally, Spire Wealth Management bought a new position in Solventum during the fourth quarter worth $37,000.

Solventum Stock Performance

Shares of SOLV stock opened at $65.97 on Wednesday. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The firm has a fifty day simple moving average of $73.88 and a two-hundred day simple moving average of $71.69. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $85.92. The firm has a market capitalization of $11.41 billion and a PE ratio of 23.99.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. Bank of America increased their price target on Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a report on Wednesday, February 26th. Morgan Stanley lifted their target price on Solventum from $73.00 to $80.00 and gave the stock an “equal weight” rating in a report on Wednesday, March 5th. The Goldman Sachs Group increased their price target on Solventum from $63.00 to $71.00 and gave the stock a “sell” rating in a report on Monday, March 3rd. Wells Fargo & Company lifted their price objective on shares of Solventum from $73.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Finally, Mizuho increased their target price on shares of Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a research note on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Solventum presently has an average rating of “Hold” and a consensus price target of $79.86.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.